The ATTD of DM decreased then increased (linear, P = 0.001; quadratic, P = 0.003) as TIU/mg of complete feed increased in the ...
Why the current system is broken and what local governments, nonprofits, and philanthropists could do to change it.
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...
Obexelimab Phase 3 INDIGO trial topline results in Immunoglobulin G4-Related Disease (IgG4-RD) expected around year-end 2025 -- Reported highly ...
Key Points Immuron receives U.S. Food and Drug administration (FDA) approval for IMM-529 Investigational New Drug (IND) ...
Q3 2025 Earnings Call Transcript November 4, 2025 Corcept Therapeutics Incorporated misses on earnings expectations. Reported ...
Milestone advances two-part study evaluating novel, locally administered gene therapy designed to increase anti-inflammatory ...
Do ultra-processed foods increase type 2 diabetes risk? Explore the link between what we eat and diabetes rates in this ...
The drug, delivered by EMS as a single injection, improved infarct-related patency at cath lab arrival and 30-day clinical outcomes.
News-Medical.Net on MSN
Daily oral medication matches injectable therapies in reducing bad cholesterol
Among people with a previous heart attack or stroke, or who are at high risk for one, a daily oral medication may offer an ...
Combined capital will support the ongoing Phase 2a clinical trial of procizumab in cardiogenic shock Hennigsdorf/Berlin, November 13, 2025 – 4TEEN4 Pharmaceuticals GmbH (“4TEEN4”) today announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback